Rising Volume of Dental Implant Surgeries Fueling Osseointegration Implant Use

The National Spinal Cord Injury Statistical Center (NSCISC) estimates that the U.S. is home to nearly 296,000 spinal cord injury (SCI) patients. As per the organization, approximately 17,900 new SCI cases are recorded in the country every year. Likewise, the Australian Institute of Health and Welfare (AIHW) states that over 15,000 Australians suffer from an SCI at any given time. The surging prevalence of SCI, on account of minor and fatal injuries caused during accidents or athletic activities, will facilitate the adoption of osseointegration implants in the forthcoming years.

Browse report with detailed COVID-19 impact analysis on Osseointegration Implants Market Competitive Landscape

Additionally, the soaring number of dental implant surgeries and growing prevalence of traumatic injuries are also expected to accelerate the osseointegration implants market at a CAGR of 4.0% during the forecast period (2018�"2023). The market revenue stood at $9.9 billion in 2017 and it is projected to reach $12.5 billion by 2023. In recent years, the surging use of titanium in osseointegration implants and increasing research on mini dental implants have become prominent market trends. 

Currently, the prominent players of the osseointegration implants market are focusing on acquisitions and product launches to gain a competitive edge. For instance, in December 2017, The Straumann Group acquired Same Day Solutions (SDS), a Lisbon-based dental implants distribution company, to share its product portfolio with the latter and increase its sales in Portugal. The other major players opting for such strategic measures are DePuy Synthes Products Inc., Zimmer Biomet Holdings Inc., Cochlear Ltd., Danaher Corporation, NuVasive Inc., and Stryker Corporation. 

Whereas, the Asia-Pacific (APAC) osseointegration implants market is expected to showcase the fastest growth during the forecast period, owing to the growing disposable income of people and increasing research and development (R&D) activities in the region. Additionally, the flourishing dental tourism industry in India and Thailand will also augment the demand for osseointegration implants in APAC. Besides, the surging focus of technologically advanced countries, such as Australia, on the development of implantable procedures for lower and upper limb amputees will also complement the market growth in the region.